Cargando…
ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
OBJECTIVE: Long-chain acyl-coenzyme A synthases (ACSLs) catalyze the activation of fatty acid and are often dysregulated in malignancies. The purpose of this research was to figure out the ACSL3's prognostic value and mechanism in clear cell renal cell carcinoma (ccRCC). METHODS: The expression...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632962/ https://www.ncbi.nlm.nih.gov/pubmed/36338658 http://dx.doi.org/10.3389/fsurg.2022.909854 |
_version_ | 1784824155993014272 |
---|---|
author | Zhang, Chiyu Hu, Honglin Huang, Ruizhen Huang, Gaomin Xi, Xiaoqing |
author_facet | Zhang, Chiyu Hu, Honglin Huang, Ruizhen Huang, Gaomin Xi, Xiaoqing |
author_sort | Zhang, Chiyu |
collection | PubMed |
description | OBJECTIVE: Long-chain acyl-coenzyme A synthases (ACSLs) catalyze the activation of fatty acid and are often dysregulated in malignancies. The purpose of this research was to figure out the ACSL3's prognostic value and mechanism in clear cell renal cell carcinoma (ccRCC). METHODS: The expression of ACSL3 in ccRCC was investigated in this work using data from the GEO, TCGA, Oncomine and HPA databases. The expression differences of ACSL3 in the cell lines were further detected by qPCR and Western blot. GEPIA, MethSurv, cBioPortal, and the TIMER were used to perform survival and correlation analysis on ACSL3. GO and KEGG analyses were carried out in R using clusterProfiler and GOplot. Protein-protein interactions (PPI) are constructed from Strings website, and the results were visualized in Cytoscape software. RESULTS: The expression level of ACSL3 was significantly reduced in ccRCC tissues, and its mRNA and protein expression were also significantly lower in both renal cancer cell lines. ACSL3 is significantly related to clinical stage, OS, DFS, DNA methylation, and immune-cell infiltration. CONCLUSION: Our findings demonstrated that data mining was capable of eliciting information on ACSL3 levels and its role in genetic regulatory pathways in ccRCC. |
format | Online Article Text |
id | pubmed-9632962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96329622022-11-04 ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma Zhang, Chiyu Hu, Honglin Huang, Ruizhen Huang, Gaomin Xi, Xiaoqing Front Surg Surgery OBJECTIVE: Long-chain acyl-coenzyme A synthases (ACSLs) catalyze the activation of fatty acid and are often dysregulated in malignancies. The purpose of this research was to figure out the ACSL3's prognostic value and mechanism in clear cell renal cell carcinoma (ccRCC). METHODS: The expression of ACSL3 in ccRCC was investigated in this work using data from the GEO, TCGA, Oncomine and HPA databases. The expression differences of ACSL3 in the cell lines were further detected by qPCR and Western blot. GEPIA, MethSurv, cBioPortal, and the TIMER were used to perform survival and correlation analysis on ACSL3. GO and KEGG analyses were carried out in R using clusterProfiler and GOplot. Protein-protein interactions (PPI) are constructed from Strings website, and the results were visualized in Cytoscape software. RESULTS: The expression level of ACSL3 was significantly reduced in ccRCC tissues, and its mRNA and protein expression were also significantly lower in both renal cancer cell lines. ACSL3 is significantly related to clinical stage, OS, DFS, DNA methylation, and immune-cell infiltration. CONCLUSION: Our findings demonstrated that data mining was capable of eliciting information on ACSL3 levels and its role in genetic regulatory pathways in ccRCC. Frontiers Media S.A. 2022-09-14 /pmc/articles/PMC9632962/ /pubmed/36338658 http://dx.doi.org/10.3389/fsurg.2022.909854 Text en © 2022 Zhang, Hu, Huang, Huang and Xi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Zhang, Chiyu Hu, Honglin Huang, Ruizhen Huang, Gaomin Xi, Xiaoqing ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title | ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title_full | ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title_fullStr | ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title_full_unstemmed | ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title_short | ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
title_sort | acsl3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632962/ https://www.ncbi.nlm.nih.gov/pubmed/36338658 http://dx.doi.org/10.3389/fsurg.2022.909854 |
work_keys_str_mv | AT zhangchiyu acsl3isapotentialprognosticbiomarkerforimmuneinfiltrationinclearcellrenalcellcarcinoma AT huhonglin acsl3isapotentialprognosticbiomarkerforimmuneinfiltrationinclearcellrenalcellcarcinoma AT huangruizhen acsl3isapotentialprognosticbiomarkerforimmuneinfiltrationinclearcellrenalcellcarcinoma AT huanggaomin acsl3isapotentialprognosticbiomarkerforimmuneinfiltrationinclearcellrenalcellcarcinoma AT xixiaoqing acsl3isapotentialprognosticbiomarkerforimmuneinfiltrationinclearcellrenalcellcarcinoma |